Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015

Related Enduring Materials

Enduring Materials

Day 1 - Friday, 4 December 2015

Session 1: Current Treatment Options -

Approved Regimens for Non ‐Cirrhotic Patients

Graham Foster, FRCP, PhD

University of London, UK

Slideset

Approved Regimens for Cirrhotic Patients

Marina Berenguer

La Fe University Hospital, Valencia, Spain

Slideset

Next Generation Regimens

Joost Drenth, MD

Radboud University Medical Center, Netherlands

Slideset

Session 2: Live Webcast Session ‐ Panel Debate -

Panel Debate

Stefan Zeuzem, MD

J.W. Goethe University Hospital, Germany

Moderators: Fred Poordad, MD

University of San Antonio Health Science Center, USA

Rafael Esteban, MD

Hospital Vall’ Hebron, Spain

Slideset

Panel members: Graham Foster, FRCP, PhD

University of London, UK

Panel members: Robert Flisiak, MD, PhD

Medical University of Bialystok, Poland

Session 3: Treatment Challenges in Special Population -

Renal Failure

Robert Flisiak, MD, PhD

Medical University of Bialystok, Poland

Decompensated Cirrhosis

Thomas Berg, MD

University of Leipzig, Germany

Slideset

Liver Cancer

Massimo Colombo, MD

University of Milan, Italy

Slideset

Viral Co‐Infection

Mark Nelson, MA, MBBS, FRCP

Chelsea and Westminster Hospital / Imperial College Medical School, United Kingdom

Slideset

Day 2 - Saturday, 5 December 2015

Session 4: Treatment Around the World (Clin. Case based) -

Patients in the US

Fred Poordad, MD

University of San Antonio Health Science Center, USA

Slideset

Patients in Germany

Heiner Wedemeyer, MD

Essen University Hospital, Germany

Slideset

Patients in Poland

Robert Flisiak, MD, PhD

Medical University of Bialystok, Poland

Slideset

Patients in Holland

Rob de Knegt, MD, PhD

Erasmus University, Netherlands

Slideset

Patients in Spain

Maria Buti, MD, PhD

Hospital General Universitari Valle Hebron, Spain

Slideset

Industry Supported Session ‐ AbbVie

Session 5: Resistance to DAAs -

Resistance Case and Preventing Resistance

Stéphane Chevaliez, PharmD, PhD

University of Paris-Est Creteil, France

Slideset

German Hepatitis C Resistance Registry

Christophe Sarrazin, MD

Goethe University Frankfurt, Germany

Slideset

Overview

We are looking back on a very succesful fifth edition of the Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice, held in Amsterdam, the Netherlands on 4- 5 December 2015.

The Program Committee and the organizing secretariat would like to thank the invited speakers and all participants for their contribution to this meeting! In particular we would like to thank our workshop sponsors Gilead, AbbVie, Janssen, and Bristol-Myers Squibb. Without their financial contribution, this workshop would not have been made possible.

Yours sincerely,

The Program Committee

Stefan Zeuzem, MD

J.W. Goethe University Hospital, Germany

Charles Boucher, MD, PhD

Erasmus Medical Center, The Netherlands

Fred Poordad, MD

University of San Antonio Health Science Center, USA

Support

Platinum Level

Gold Level

Support

Endorsers